The Michael J. Fox Foundation Expands Landmark Parkinson’s Research Study toward Better Treatments and Prevention
$750-million gold-standard Parkinson's Progression Markers Initiative (PPMI) study lowers risk screening eligibility age from 60 to 40 to explore earlier signs of pathology, including loss of smellExpansion of PPMI study


